ストックスクリーナーアプリを入手
11.83
1.66%
-0.20
アフターアワーズ：
11.83
Generate Biomedicines Inc (GENB) 最新ニュース
Flagship-backed Generate Bio seeks $425 million in US IPO - MSN
Generate Biomedicines gains buy initiations from Guggenheim, Piper Sandler - Seeking Alpha
Generate Biomedicines (NASDAQ:GENB) Coverage Initiated at Piper Sandler - MarketBeat
Generate Biomedicines (NASDAQ:GENB) Coverage Initiated at Guggenheim - MarketBeat
Generate Biomedicines (NASDAQ:GENB) Earns Overweight Rating from Analysts at Cantor Fitzgerald - MarketBeat
Goldman Sachs Initiates Coverage on Generate Biomedicines With Buy Rating, $26 Price Target - marketscreener.com
Guggenheim Initiates Coverage on Generate Biomedicines With Buy Rating, $30 Price Target - marketscreener.com
This KB Home Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Benzinga
Morgan Stanley Initiates Generate Biomedicines at Overweight With $20 Price Target - marketscreener.com
Morgan Stanley initiates Generate Biomedicines stock at overweight By Investing.com - Investing.com Canada
Goldman Sachs initiates Generate Biomedicines stock with buy rating on AI platform potential - Investing.com Canada
Guggenheim initiates Generate Biomedicines stock with buy rating - Investing.com
Guggenheim initiates Generate Biomedicines stock with buy rating By Investing.com - Investing.com UK
Generate Biomedicines IPO Turns Heads - Yahoo! Finance Canada
Generate Biomedicines (GENB) Stock Trends and Sentiment 2026 - MarketBeat
Free cash flow per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Total debt per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Book value per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Revenue per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (GENB) 10K Form and SEC Filings 2026 - MarketBeat
Total liabilities & shareholders' equities of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
After tax other income/expense of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
EBIT of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Pretax income of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines, Inc. Income Statement – NASDAQ:GENB - TradingView
Generate Biomedicines, Inc. Dividends – NASDAQ:GENB - TradingView
Net debt of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Tangible book value per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Cash from investing activities of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Free cash flow of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines, Inc. Cash Flow – NASDAQ:GENB - TradingView
Long term debt to total assets ratio of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Total liabilities of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Enterprise value to EBITDA ratio of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Price to sales ratio of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
GENB News Today | Why did Generate Biomedicines stock go down today? - MarketBeat
Working capital per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (GENB) Stock Price, News & Analysis - MarketBeat
Generate Biomedicines (NASDAQ:GENB) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Total equity of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines, Inc.Common Stock (Nasdaq:GENB) Stock Quote - FinancialContent
Return on assets % of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Total assets of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Price to cash flow ratio of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Total common shares outstanding of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (NASDAQ: GENB) holder reports 1.56M-share stake - Stock Titan
GENB SEC FilingsGenerate Biomedicines 10-K, 10-Q, 8-K Forms - Stock Titan
Generate Biomedicines (GENB) Stock Forecast and Price Target 2026 - MarketBeat
Fpn Ii, L.p. Net Worth (2026) - GuruFocus
Generate Biomedicines (GENB) Stock Chart and Price History 2026 - MarketBeat
Goodwin Advises Generate Biomedicines, Inc. On The Closing Of Its $400 Million Initial Public Offering - Mondaq
Latest GENB ETF News Today | Earnings, Events & Price Alerts - Intellectia AI
GENB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
GENB Technical Analysis & Stock Price Forecast - Intellectia AI
Diluted net income available to common stockholders of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Dilution adjustment of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (GENB) Valuation Check After Recent Share Price Weakness - Yahoo Finance
Generate Biomedicines Inc. (GENB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Generate Biomedicines IPO Opens Nasdaq Chapter And Investor Watch Period - simplywall.st
Generate Biomedicines, Inc. Cash Flow – BOATS:GENB - TradingView
1.82%
大文字化:
|
ボリューム (24 時間):